Government
PRODUCTS
-
Precise, Complete, and Ultimate Detection.
A premium dual energy x-ray inspection system offering outstanding detection of hard-to-find, low density contaminants, in a variety of applications. Available in standard and custom configurations
Detect Hard-to-Find Contaminants
Capable of detecting hard-to-find contaminants in a variety of applications. Offering clarity and precision in complex areas of product inspection.
Enhance Product Quality
Achieves outstanding product quality using advanced levels of foreign body detection of low-density contaminants in overlapping products.
Increase Productivity
Clever design combined with an intuitive user interface to create user-friendly systems that increase uptime and boost productivity.
-
IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.
-
The healthcare industry demands durable, cleanable, and safe environments. Arcoplast offers a comprehensive solution for critical areas like operating rooms, cleanrooms, and compounding pharmacies.
-
Natoli Scientific’s preclinical stability studies represent a critical facet of our pharmaceutical testing services, providing essential data on the shelf life and storage conditions of drug candidates. These studies are expertly designed to evaluate physical, chemical, and microbiological stability, ensuring that formulations retain their safety, efficacy, and quality over time. Our state-of-the-art facilities simulate various environmental conditions to scrutinize the integrity of products under stress-testing scenarios. The results gleaned from our stability studies guide the development of robust drug formulations and packaging, aid in regulatory submissions, and lay the groundwork for successful commercialization.
-
Why Patient Recruitment Matters in Clinical Research
Patient recruitment is one of the most critical aspects of a clinical trial’s success. Without an adequate and diverse participant pool, trials risk failing to generate reliable and representative data. Ensuring sufficient participation is essential for producing statistically valid results that confirm the treatment's safety and effectiveness.
For biotech companies, especially those under tight timelines and budgets, partnering with an experienced CRO like Novotech ensures that patient recruitment efforts are both efficient and effective, enabling timely trial completion and robust data collection.
WHITE PAPERS AND CASE STUDIES
-
Leveraging Life Sciences Data For Intelligent Decision-Making
Industry 4.0 drives life sciences to prioritize data-driven decision-making by integrating advanced technologies in QMS. Discover how modern data management can improve compliance.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing
For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.
-
The Evolution Of Antibody-Drug Manufacturing
Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
-
Unlock Oncology Success With A Comprehensive Commercialization Guide
Navigate the complex process of bringing an oncology therapy to market, from regulatory planning to patient access and supply chain logistics, with this comprehensive handbook for developers.
-
Pittsburgh Water Sets New Standard With Customer Request Sampling To Support Lead Service Line Replacement
Discover how 120Water helped Pittsburgh Water reduce their turnaround times, streamline sampling workflows, and save hours of work. Learn how you can also use sampling to support your replacement and community engagement programs with their case study.
-
Putting The Squeeze In Sponge Cities: Amsterdam's Waternet And The Innovative RESILIO Blue-Green Roof Project
The RESILIO project has helped Amsterdam repurpose rooftops as smart blue-green roofs to reuse rainwater and prevent localized flooding. This project, along with other sustainable water initiatives like the Amsterdam Rainproof program, continues to position the Netherlands at the forefront of water management.
-
How To Adopt CSA For Streamlined Computer System Validation
Discover how the FDA’s Computer Software Assurance guidance modernizes validation by reducing compliance burdens and fostering innovation through a streamlined approach to system validation.
-
Is The Water Sector Ready For AI?
Despite AI's potential to transform the water sector, fewer than half of organizations are fully ready for adoption. The biggest challenges are procedural and cultural, like fear of change and workforce readiness. Focus on these internal barriers to gain measurable efficiency and sustainability benefits.
-
15 Reasons To Implement RFID In Medical Devices
Discover the importance of integrating RFID technology into medical devices for improved tracking, supply chain management, and patient safety — enhancing security, traceability, and compatibility.
-
World's Largest 1,4-Dioxane Treatment Initiative
Groundwater on Long Island, New York, contains the contaminant 1,4-dioxane. Despite no federal regulation, local water providers and state authorities have taken action to address contamination, establishing a state-enforced maximum contaminant level.
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
NEWS
-
HGACBuy Contract Awarded To FieldLogix5/9/2025
FieldLogix, the leading provider of Field Resource Management technology, is proud to announce that it has been re-awarded a cooperative purchasing contract by the Houston-Galveston Area Council (HGACBuy).
-
Geotab Expands Sourcewell Contract Adding Video Telematics, Asset Tracking, Data Analytics Solutions For Public Sector12/15/2025
Geotab Inc. (“Geotab”), a global leader in connected vehicle solutions and asset management, today announced a significant expansion of its cooperative purchasing contracts with Sourcewell and Canoe Procurement Group.
-
Blue Mantis Expands Federal IT Services Portfolio Under GSA Contract7/22/2025
Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity, and cloud solutions, today announced its expanded service offerings under the U.S. General Services Administration (GSA) Multiple Award Schedule (MAS), specifically under Special Item Number (SIN) 54151S for Information Technology Professional Services.
-
Biosimilars Council Executive Director Craig Burton Testifies Before Congress On Biosimilars Crisis4/8/2025
The Biosimilars Council today released Congressional testimony provided by Craig Burton, Executive Director of the Biosimilars Council before the House Ways & Means Health Subcommittee hearing: Lowering Costs for Patients: The Health of the Biosimilar Market.
-
Hughes And Celona To Deliver Fully Managed Private Wireless Networks10/7/2025
Hughes Network Systems, LLC (Hughes), an EchoStar company, today announced a strategic relationship with Celona, a pioneer in private 5G networks, to launch a fully managed private wireless network solution.